Enhertu Approved in Singapore for Previously Treated HER2-Positive Advanced Breast and Gastric Cancer
AstraZeneca delivers promising new treatment, one of the fastest-developed biologics in oncology, to address the high unmet need for third-line treatment. Enhertu (trastuzumab deruxtecan) has been...